xB3-001 & Chemobraindigitel, you should read what you copy/paste here.
I gave it a 10-minute look. The study was with trastuzumab (TZB) and atorvastatin (Lipitor) in a nude mouse model with HER2+ gastric cancer. It's recognized in the study that the chemobrain may be mouse model and receptor dependent. And Lipitor mitigated it. (That's the good news!) And in the study, TZB never entered the brain. And that there is a receptor involved that could be targeted as a mitigator.
Further, since TZM MAY have been involved, since the study was NOT about brain tumours, since the study was done with suspicious nude mice, but since TZM has been used for over 20 years with immense success, why are you being this irresponsible?
You have no idea what you're talking about, digitel, and you know why? Because copy/pasting isn't "learning," "thinking" or "talking" about anything. It's simply the movement of words around, without knowing what the words even are, let alone what they mean.
Read the paper before you post it!
There are profoundly compelling reasons why the PhDs and MDs at Bioasis are moving xB3-001 to the clinic.
So, minedigger, how should I respond to such irresponsible behaviour as this?
Awe, gee, Mr. Digitel, I, ah, I really appreciate that you gave us your thoughts on this but maybe we should take a little look at so we, maybe, might know WTF we're talking about!